1 Publication
2019
A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2- metastatic breast cancer (MBC)
Anders, Carey K⋅Le Rhun, Emilie⋅Bachelot, Thomas Denis⋅Yardley, Denise A⋅Awada, Ahmad⋅Conte, Pier Franco⋅Kabos, Peter⋅Bear, Melissa⋅Yang, Zhengyu⋅Chen, Yanyun and Tolaney, Sara M
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 1017, 2019-05-20. | Journal Article